AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vensor 37.5mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ryon Pharma

Salt Composition

Venlafaxine (37.5mg)

Overview Vensor 37.5mg Tablet SR

Deprexa SR 37.5mg tablets treat depression and anxiety. This medication modifies brain chemistry, alleviating symptoms like irritability, restlessness, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take Deprexa SR 37.5mg with food, consistently at the same time daily for stable blood levels. If a dose is missed, take it immediately upon remembering; don't skip doses, and complete the prescribed course, even feeling improved. Abrupt cessation may intensify symptoms. Common side effects include nausea, vomiting, sleeplessness, reduced appetite, anxiety, constipation, increased sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or tasks demanding focus until effects are known. These side effects are usually transient. Consult your physician if they persist. Before starting Deprexa SR 37.5mg, disclose any kidney, heart, or liver issues, or history of seizures. Report any unusual mood or behavior changes, worsening depression, or suicidal thoughts to your doctor.

Primary Ingredients of Vensor 37.5mg Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Vensor 37.5mg Tablet SR

Mood disorders encompassing depressive and anxious symptoms

Major Benefits of Vensor 37.5mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vensor 37.5mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

Common Side effects of Vensor 37.5mg Tablet SR:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Vensor 37.5mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vensor 37.5mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Vensor 37.5mg Tablet SR works:

Vensor 37.5mg Extended-Release Tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Vensor 37.5mg Tablet SR use is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Vensor 37.5mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vensor 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Close observation of infants for drowsiness and satisfactory weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Vensor 37.5mg Tablet SR, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vensor 37.5mg Extended-Release tablets cautiously. Dosage modification of Vensor 37.5mg Extended-Release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

For individuals with hepatic impairment, Vensor 37.5mg sustained-release tablets require careful administration. Dosage modification of Vensor 37.5mg sustained-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Vensor 37.5mg Tablet SR :

For Vensor 37.5mg SR tablets, take a missed dose promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vensor 37.5mg Tablet SR

LabelValue
Chemical Type Anisole-based Compound
Developing Habits No.
Treatment Category Neuroscience Central Nervous System
Action Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Vensor 37.5mg Tablet SR

Sedation is a possible side effect of Vensor 37.5mg Tablet SR. Disclose any other sleep aids you're using to your doctor before starting this medication.
Yes. Vensor 37.5mg SR tablets are psychotropic medications; these affect mental processes, emotions, and behavior.
Vensor 37.5mg SR tablets are not narcotics. Narcotics are opioid derivatives, such as heroin and morphine, known for their sedative effects.
Vensor 37.5mg Tablets SR, ER, and XR are all extended-release formulations, delivering medication slowly for consistent therapeutic levels. This extended-release design allows for less frequent dosing.
Mirtazapine and Vensor 37.5mg SR tablets together pose a serious risk of serotonin syndrome. This potentially life-threatening condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma.
Combining citalopram and Vensor 37.5mg SR tablets, which both raise serotonin levels, risks causing serotonin syndrome. This potentially life-threatening condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma. An alternative medication should be considered.
Vensor 37.5mg Tablet SR is removed from the brain by P-glycoprotein. However, some research indicates that Vensor 37.5mg Tablet SR and its metabolite can inhibit this transporter.
Vensor 37.5mg extended-release tablets are absorbed in the intestine following hepatic metabolism.
Vensor 37.5mg Extended-Release Tablets are prescribed for generalized depressive disorder. Always consult a physician before use.
Vensor 37.5mg Tablet SR may cause sustained high blood pressure in some patients. Regular blood pressure monitoring is recommended for those taking this medication; dose reduction or treatment discontinuation may be necessary.
Yes, Vensor 37.5mg SR tablets can cause constipation. Increase your fiber intake and fluid consumption. Laxatives may be helpful. Your doctor can advise on prevention and management. Consult your doctor if constipation persists or worsens.
Yes, Vensor 37.5mg SR tablets have been associated with weight loss in some patients. Studies show this weight loss increases with higher doses and longer treatment durations. Consult your doctor if this concerns you.
Vensor 37.5mg SR tablets are not habit-forming.
Always consult your doctor before substituting a tablet for a capsule. The differing formulations may affect drug release and treatment efficacy, potentially causing side effects or treatment failure. Never make this change independently.
Yes, gabapentin can be combined with Vensor 37.5mg SR tablets, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active ingredient in Vensor 37.5mg SR tablets.
Vensor 37.5mg Tablet SR is not currently FDA-approved for fibromyalgia, although some studies suggest potential benefits. Always consult your physician before using this medication to treat fibromyalgia.
While not FDA-approved for nerve pain, Vensor 37.5mg SR tablets have shown efficacy in some research studies, leading to their off-label use in managing this condition.
Vensor 37.5mg SR tablets alter brain neurotransmitter levels, resulting in dose-dependent appetite suppression.
Should you experience side effects such as reduced libido or erectile dysfunction, consult your doctor to discuss alternative medication options. Do not discontinue Vensor 37.5mg Tablet SR without medical supervision; doing so may worsen side effects.
Vensor 37.5mg Tablet SR
35
MRP 40
12% off